-
The regulator has also paused the redemption of the company’s $20mn Tier 2 floating-rate subordinated notes. -
The R&Q share price has plummeted since the sale of the ~$1.8bn-premium fronting arm was announced 10 days ago.
-
The revised status follows the recent announcement that R&Q Insurance Holdings has agreed a sale of its Accredited program.
-
The bids received did not meet the seller’s reserve price, and it is likely to remarket the unit in two to three years.
-
R&Q expects ongoing operating losses after the sale as transitions its legacy business to a fee-based model.
-
Halfway through a complex restructuring is not the time for a CEO (and CFO) change.
-
R&Q CEO William Spiegel will transfer to the Accredited program management business.
-
Darag’s German outfit completed the transaction to assume expired long-term liability insurance policies from the undisclosed captive.
-
The seller is facing an uphill struggle convincing its legacy rivals that there is strategic value in the merger deal.
-
Although the total deal values for 2022 and 2023 were almost identical, PwC noted that one-third fewer deals were announced in the more recent half-year period.
-
Catalina put its Irish subsidiary up for sale in May as it looks to streamline operations.
-
The insurer has been working to build a reputation for favorable reserve development after past sins.
